Results 251 to 260 of about 1,127,916 (265)

Radiotherapy for Liver Metastases: A Review of Evidence

International Journal of Radiation Oncology Biology Physics, 2012
Brian Kavanagh, Morten Høyer, Michael Lock   +2 more
exaly  

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)†

Annals of Oncology, 2014
Thomas Gruenberger, Wolf Otto Bechstein, Gunnar Folprecht   +2 more
exaly  

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

Cancer Treatment Reviews, 2015
Alberto Sobrero, Laura Rubbia-Brandt, Eric Van Cutsem   +2 more
exaly  

Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections

Annals of Oncology, 2007
Emilio Ramos, Fernando Burdio, S Mojal
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Rebecca L. Siegel, Ahmedin Jemal, Kimberly D Miller   +2 more
exaly  

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Annals of Oncology, 2014
J B Vermorken, X Durando, S Negrier
exaly  

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

Annals of Oncology, 2012
Wolf Otto Bechstein, C Punt, T Ruers
exaly  

Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients

Annals of Oncology, 2008
Hein Putter, Hans J. Gelderblom, Alexander L Vahrmeijer   +2 more
exaly  

Breast Liver Metastases – Incidence, Diagnosis and Outcome

Journal of the Royal Society of Medicine, 1991
G T Royle
exaly  

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

Annals of Oncology, 2015
John Bridgewater, Thomas Gruenberger, Ian Chau   +2 more
exaly